Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Feb 2, 2023
- Accession no.
- 0001415889-23-001810
- Filed
- Feb 2, 2023
- Trade date
- Feb 2, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.53M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2023 | Common Stock | MOption exerciseAcquired | +6,000 | $120.26 | +$721,560 | 42,397 | Direct | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −4,400 | $254.17F2 | −$1,118,348 | 37,997 | Direct | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −1,400 | $255.46F3 | −$357,644 | 36,597 | Direct | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −200 | $258.99 | −$51,798 | 36,397 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2023 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 62,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $253.77 to $254.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $255.04 to $255.975. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.